Restriction on length of Malarone use lifted

Prescribing information for Malarone and Malarone Paediatric (atovaquone/proguanil) has been updated to remove the maximum recommended duration of use.

Malarone should be initiated 24–48 hours before entering a malaria endemic area | SCIENCE PHOTO LIBRARY
Malarone should be initiated 24–48 hours before entering a malaria endemic area | SCIENCE PHOTO LIBRARY

Use of the antimalarials for the prophylaxis of P. falciparum disease is no longer limited to a maximum of 28 days in an endemic area. The duration of use should now be determined by the prescriber.

Guidance issued by the HPA in 2007 suggests that Malarone can be used for up to one year or longer.

View Malarone and Malarone Paediatric drug records

Follow MIMS on Twitter


Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Alert:
Urgent prescribing updates
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases